Gujarat Themis
Biosyn Limited
About
The GTBL Story
Company Overview
The Themis Medicare Group
Our Milestones
Chairman's Desk
The Board
The Management Committees
Business Partners
CSR Activities
Products
Capabilities
CDMO
Innovation
Media
News
(Coming Soon)
Events
(Coming Soon)
Investor Relations
Careers
Contact
Investor Relations
Investor Relations
Disclosures under regulation 46 of LODR
Policies and Code
Annual Secretarial Compliance Reports
Investor Contacts
Shareholding Pattern
Credit Rating
Investor Meet
Notifications
Recordings
Transcripts
Board Meetings
Board Meetings Intimation
Board Meetings Outcome
Board Meetings Newspaper Publications
Annual General Meetings
AGM Notice
AGM E Voting Result
AGM Newspaper Publications
Extraordinary General Body Meetings
EGM - Notice
EGM - E Voting Result
EGM - Newspaper Publication
Postal Ballot
Postal Ballot Notice
Postal Ballot E Voting Result
Postal Ballot Newspaper Publications
Corporate Social Responsibility Approved Projects
Investor Presentations
SMART ODR
Reports
Unclaimed Dividends
Stock Price
KYC Forms
MOA & AOA
Schemes
Financial Snapshot
Quarterly results
Schemes
Scheme of Amalgamation
Joint Valuation Report with Undertaking.
Audit Committee Report
Draft Board Report.
Fairness Opinion Report
Auditor certificate on accounting treatment;
Detailed Compliance Report;
Independent Directors Committee Report;
Confirmation on no-debt obligations;
No Objection Certificate (NOC) from the lending scheduled commercial banks/financial institutions/debenture trustees
Declaration from the listed entity in terms of Clause 2 of Para A of Part I of the SEBI Master Circular dated June 20, 2023
Report on complaints related to Merger Scheme in terms of Paragraph 6.a of Part I(A) of the SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20, 2023 as amended from time to time ("SEBI Master Circular").
Revised Scheme of Amalgamation
Investor Relations
Schemes